U94 alters FN1 and ANGPTL4 gene expression and inhibits tumorigenesis of prostate cancer cell line PC3

BACKGROUND: Insensitivity of advanced-stage prostate cancer to androgen ablation therapy is a serious problem in clinical practice because it is associated with aggressive progression and poor prognosis. Targeted therapeutic drug discovery efforts are thwarted by lack of adequate knowledge of gene(s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ifon, Ekwere T, Pang, Alan LY, Johnson, Warren, Cashman, Kathleen, Zimmerman, Sharon, Muralidhar, Sumitra, Chan, Wai-Yee, Casey, John, Rosenthal, Leonard Jason
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1200560/
https://www.ncbi.nlm.nih.gov/pubmed/15972109
http://dx.doi.org/10.1186/1475-2867-5-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1200560/
https://www.ncbi.nlm.nih.gov/pubmed/15972109
http://dx.doi.org/10.1186/1475-2867-5-19

Ejemplares similares